Cargando…
Risk of Clostridium difficile Infection with the Use of a Proton Pump Inhibitor for Stress Ulcer Prophylaxis in Critically Ill Patients
BACKGROUND/AIMS: Proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) are commonly prescribed for stress ulcer prophylaxis (SUP) in critically ill patients. Several studies have suggested that the use of PPIs is a potential risk factor for Clostridium difficile infection (CDI)....
Autores principales: | Ro, Youngouk, Eun, Chang Soo, Kim, Hyun Soo, Kim, Ji Yeoun, Byun, Young Jae, Yoo, Kyo-Sang, Han, Dong Soo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Editorial Office of Gut and Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933419/ https://www.ncbi.nlm.nih.gov/pubmed/27021503 http://dx.doi.org/10.5009/gnl15324 |
Ejemplares similares
-
Does Proton Pump Inhibitor Increase the Clostridium difficile Infection Risk in the Treatment and Prophylaxis of Stress Ulcers than Histanime-2 Receptor Antagonist?
por: Eun, Chang Soo
Publicado: (2017) -
Proton Pump Inhibitors Should be Used with Caution in Critically Ill Patients to Prevent the Risk of Clostridium difficile Infection
por: Min, Jung Hwa, et al.
Publicado: (2016) -
Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients
por: Barletta, Jeffrey F, et al.
Publicado: (2014) -
The submucosal fibrosis: what does it mean for colorectal endoscopic submucosal dissection?
por: Kim, Eun Kyoung, et al.
Publicado: (2016) -
Does Lymphocytic Colitis Always Present with Normal Endoscopic Findings?
por: Park, Hye Sun, et al.
Publicado: (2015)